News ( Year: 2021 )

SORT BY YEAR
3 March, 2021

RefleXion Adds Ally Bridge Group to Investor Syndicate

Expands Series D financing by $40M March 02, 2021 10:00 AM Eastern Standard Time HAYWARD, Calif.–(BUSINESS WIRE)–RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the successful completion of a $40 million extension to its Series D financing, which combined with $110 million raised […]

Read More
17 February, 2021

ABG Acquisition Corp. I Announces Pricing of Upsized $131 Million Initial Public Offering

NEW YORK and HONG KONG, Feb. 16, 2021 /PRNewswire/ — ABG Acquisition Corp. I (the “Company”) today announced the pricing of its initial public offering of 13,100,000 Class A ordinary shares at a price of $10.00 per share. The shares will be listed on The Nasdaq Capital Market and trade under the ticker symbol “ABGI” […]

Read More
16 February, 2021

Ally Bridge Group Co-leads Mainstay Medical’s $108 Million Equity Financing

Funding to support U.S. commercial launch and global expansion February 16, 2021 08:00 AM Eastern Standard Time DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity financing in which it raised gross proceeds of US$108 million. Mainstay intends to use the funds to support the company’s commercial launch […]

Read More
8 February, 2021

Ally Bridge Portfolio News – Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

Nautilus Biotechnology has entered into a definitive merger agreement with Arya Sciences Acquisition Corp III (Nasdaq: ARYA). Upon closing, the combined company is expected to be listed on Nasdaq under the ticker symbol “NAUT” Nautilus Biotechnology is expected to receive $350 million in proceeds through the business combination, including a $200 million fully committed PIPE […]

Read More
3 February, 2021

Syapse Announces $68 Million Strategic Investment with Ally Bridge Group and Northpond Ventures to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

February 02, 2021 10:00 ET — Financing to support expanded partnering opportunities with life sciences, health systems, regulators and molecular labs — — Syapse committed to delivering real-world insights to improve outcomes for people with cancer — SAN FRANCISCO and NEW YORK and HONG KONG, Feb. 02, 2021 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company […]

Read More